Looking for space?
Login

Strengthening the Oss pharma cluster through the arrival of Aspen Oss at Pivot Park

Oss, 18 December 2025

Pivot Park and Aspen Oss, both based in Oss and neighbours, have signed an important lease and development agreement for Aspen Oss to occupy the Hodgkin building, commonly known as Panther, at Pivot Park. The exploratory phase for the interior configuration of Panther has now been completed and the aim is for the first employees to move into the building in June 2027.

Following the completion of the exploratory phase, significant progress has been made towards the final design. All parties involved have worked intensively together to be ready in time for the next phase: the development of a technical design. This will allow the construction of the new building to proceed according to schedule.

This step will allow Aspen Oss and its sister company BioChem Oss to consolidate all laboratory activities that are currently carried out in multiple buildings at the Moleneind site in Oss.

“The new state-of-the-art building on the Pivot Park campus will provide modern facilities for both laboratory and office functions and aligns seamlessly with the ambitions of Aspen Oss and BioChem Oss. The building complies with all industrial hygiene and safety regulations, is designed with future proofing and sustainability in mind and meets the highest standards for energy efficiency. It also strengthens our attractiveness as a partner for customers and for new and existing talent,“ says Marcel Broecks, Managing Director of Aspen Oss.

Expansion of the ecosystem

Pivot Park is very pleased with the collaboration with Aspen Oss. “Panther has been waiting for some time to be brought into use. We are therefore especially delighted that together with Aspen we have signed these contracts within the Oss biopharma cluster. This strengthens the ecosystem that is so vital for a campus such as Pivot Park,“ says Brigitte Drees, CEO of Pivot Park.

About Pivot Park

Pivot Park is the hotspot for companies and knowledge institutes in the biopharmaceutical industry. More than 1,000 people work on the campus across 60+ start ups, scale ups and established companies specialising in innovative drug development and pharmaceutical manufacturing. Pivot Park provides sustainable real estate, facilities and services and offers access to knowledge, entrepreneurship and a dynamic community. Pivot Park in Oss has everything required to develop Europe’s leading biopharmaceutical campus for a community united in improving global health.

For more information, please visit www.pivotpark.com or email info@pivotpark.com.

About Aspen Oss

Aspen is an international pharmaceutical company and part of Aspen Pharmacare, one of the largest pharmaceutical companies in the Southern Hemisphere with operations in more than 50 countries. In the Netherlands, Aspen operates through Aspen Oss and BioChem Oss with three locations in Oss and Boxtel. Aspen Oss produces high quality APIs for applications including oncology, neurology, anticoagulation, reproductive health, addiction care and muscle relaxation. BioChem Oss focuses on heparin APIs and CDMO services for biochemical products used in life saving medicines.

For more information, please visit www.aspenapi.com or www.werkenbijaspen.nl.

 

Note to editors:

  • For more information about Pivot Park, please contact Sofie Mevius, Online and Content Manager, Pivot Park: sofiemevius@pivotpark.com or +31 6 10 95 67 67.
  • For more information about Aspen Oss, please contact Ilona van Osch, Communications Advisor, Aspen Oss: ivanosch@nl.aspenpharma.com or +31 6 11 11 98 37.
Search

Recent Posts

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?
Read more (NL)

#100YEARSPHARMAFUTURE

The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.